CCNE1Amplification as a Therapeutic Target

医学 引用 图书馆学 内科学 肿瘤科 计算机科学
作者
George Au‐Yeung,Linda Mileshkin,David D.L. Bowtell
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:41 (9): 1770-1773 被引量:18
标识
DOI:10.1200/jco.22.02267
摘要

Article Tools UNDERSTANDING THE PATHWAY Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification. December 05, 2022 ARTICLE CITATION DOI: 10.1200/JCO.22.02267 Journal of Clinical Oncology - published online before print February 2, 2023 PMID: 36730890 CCNE1 Amplification as a Therapeutic Target George Au-Yeung , MBBS, PhD1,2xGeorge Au-YeungSearch for articles by this author; Linda Mileshkin , MBBS, MD1,2xLinda MileshkinSearch for articles by this author; and David D.L. Bowtell , PhD1,2xDavid D.L. BowtellSearch for articles by this author Show More 1Peter MacCallum Cancer Center, Melbourne, Victoria, Australia2Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia https://doi.org/10.1200/JCO.22.02267 First Page Full Text PDF Figures and Tables © 2023 by American Society of Clinical OncologySUPPORTSupported by the National Health and Medical Research Council of Australia: APP1117044 (D.D.L.B.), APP1092856 (D.D.L.B.), and APP2008781 (D.D.L.B.).AUTHOR CONTRIBUTIONSConception and design: All authorsFinancial support: David D.L. BowtellCollection and assembly of data: George Au-Yeung, Linda MileshkinData analysis and interpretation: George Au-Yeung, Linda MileshkinManuscript writing: All authorsFinal approval of manuscript: All authorsAccountable for all aspects of the work: All authorsAUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTERESTCCNE1 Amplification as a Therapeutic TargetThe following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jco/authors/author-center.Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).George Au-YeungResearch Funding: Roche/Genentech (Inst), AstraZeneca (Inst)David D.L. BowtellConsulting or Advisory Role: Exo TherapeuticsResearch Funding: Roche/Genentech, AstraZeneca, BeiGenePatents, Royalties, Other Intellectual Property: Henry Jackson Foundation INOVA HealthCare University of Melbourne (Inst)No other potential conflicts of interest were reported. Companion Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring CCNE1 Amplification
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
烟花的应助被铁锤牛马版采纳,获得10
刚刚
victor1995888完成签到,获得积分10
刚刚
yk发布了新的文献求助10
1秒前
1秒前
SamYang发布了新的文献求助10
1秒前
1秒前
1秒前
大模型的应助被曾经的康乃馨采纳,获得10
1秒前
霸气林完成签到,获得积分10
1秒前
超帅凡阳完成签到,获得积分20
2秒前
慕夏晚吹风完成签到 ,获得积分10
2秒前
香蕉黑米发布了新的文献求助10
2秒前
艾妮吗完成签到,获得积分10
3秒前
3秒前
sxxx完成签到,获得积分10
3秒前
hvtu发布了新的文献求助10
3秒前
阿飞发布了新的文献求助10
3秒前
丘比特的应助被肖望采纳,获得10
3秒前
DXXP完成签到,获得积分10
3秒前
彩虹糖完成签到,获得积分10
3秒前
轻松柏柳完成签到 ,获得积分10
4秒前
科研通AI6.3的应助被撝谦采纳,获得10
4秒前
Cedric完成签到,获得积分10
4秒前
袁志阳完成签到,获得积分10
4秒前
5秒前
5秒前
超帅凡阳发布了新的文献求助10
5秒前
未了发布了新的文献求助10
5秒前
cloudss发布了新的文献求助10
6秒前
6秒前
小二郎的应助被shelemi采纳,获得10
6秒前
丘比特的应助被shelemi采纳,获得10
6秒前
可爱的函函的应助被shelemi采纳,获得10
7秒前
汉堡包的应助被shelemi采纳,获得10
7秒前
CipherSage的应助被shelemi采纳,获得10
7秒前
1101592875发布了新的文献求助10
7秒前
ding的应助被shelemi采纳,获得10
7秒前
深情安青的应助被shelemi采纳,获得10
7秒前
科研痴发布了新的文献求助10
8秒前
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180586
求助须知:如何正确求助?哪些是违规求助? 9570581
关于积分的说明 21813457
捐赠科研通 7776777
什么是DOI,文献DOI怎么找? 3433294
关于科研通互助平台的介绍 2557547
邀请新用户注册赠送积分活动 2479253